Pay in 4 interest-free payments of $5.64 Learn more
Ships within 48 hours · Estimated delivery Oct 11 - Oct 16
IMU-838, a Developmental DHODH inhibitor in phase II for autoimmune disease, shows anti-SARS-CoV-2 and broad-spectrum antiviral efficacy in vitro
Higher NAD+ availability supports mitochondrial activity, which is responsible for producing most of the bodys cellular energy
Factors that increase susceptibility to this disorder include: Multiple sclerosis (MS)
A., Payne, N., Tortorelli, S., Matern, D., Rinaldo, P., Gavrilov, D., Melan, M., He, M., Steinberg, S
Ricci G, Lo Bello M, Caccurri AM, Pastore A, Nuccetelli M, Parker MW, et al
US$ 26.05
US$ 25.54
US$ 28.48
US$ 29.09
US$ 23.80
US$ 23.72
US$ 27.78
US$ 20.11
US$ 23.86
